|
13C DIM REPRESSES ANDROGEN-INDUCED TWIST 1 EXPRESSION IN HUMAN PROSTATE CANCER
|
Y01CN129005
|
$68,000
|
$68,000
|
UNKNOWN, UNKNOWN
|
U.S. NATIONAL INSTITUTES OF HEALTH
|
|
15-LOX-1 effects on colitis and colon cancer
|
5R01CA137213-04
|
$309,964
|
$154,982
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-03
|
$350,219
|
$87,555
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel agent suppresses colitis and colon cancer
|
1R03CA158669-01A1
|
$78,500
|
$78,500
|
Ouyang, Nengtai
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
A novel mouse prostate carcinogenesis model for dietary cancer prevention researc
|
1R03CA159361-01A1
|
$77,333
|
$77,333
|
Li, Guangxun
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
A pilot study of statin therapy and risk of malignant glioma
|
7K07CA127468-05
|
$135,513
|
$135,513
|
Lai, Rose
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$77,251
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-02
|
$1,474,780
|
$117,982
|
Sloan, Jeff
|
MAYO CLINIC
|
|
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
|
5R01CA129409-04
|
$307,951
|
$61,590
|
HURSTING, STEPHEN
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
|
1R01CA164041-01
|
$330,975
|
$330,975
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
AMPK as a molecular target for chemoprevention by apigenin in preneoplastic skin
|
1R21CA161181-01A1
|
$168,019
|
$168,019
|
Tong, Xin
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
An NF-kB inhibitor as a post-carcinogen lung cancer chemopreventive agent
|
5R03CA156301-02
|
$71,689
|
$71,689
|
XING, CHENGGUO
|
UNIVERSITY OF MINNESOTA
|
|
Analog Studies of 4-HPR and its Glucuronide
|
5R01CA049837-18
|
$331,716
|
$331,716
|
CURLEY, ROBERT
|
OHIO STATE UNIVERSITY
|
|
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression
|
1R43CA162734-01A1
|
$300,000
|
$300,000
|
BASU, HIRAK
|
COLBY PHARMACEUTICAL COMPANY
|
|
AnnexinA2/progastrin and stem cells: dietary cancer prevention
|
3R01CA097959-09S1
|
$56,953
|
$56,953
|
SINGH, POMILA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
AnnexinA2/progastrin and stem cells: dietary cancer prevention
|
5R01CA097959-09
|
$299,222
|
$299,222
|
SINGH, POMILA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Anti-Migration Therapy for Prevention and Treatment of Breast Tumor
|
1R01CA160271-01A1
|
$321,625
|
$321,625
|
Tanaka, Takemi
|
THOMAS JEFFERSON UNIVERSITY
|
|
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals
|
1R01CA164159-01A1
|
$467,444
|
$467,444
|
DIGIOVANNI, JOHN
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
5R01CA101753-09
|
$319,332
|
$319,332
|
Singh, Shivendra
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Anticarcinogenic Mechanisms of Tea Constituents
|
5R37CA081064-13
|
$274,147
|
$274,147
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA
|
|
Antioxidants and Antiinflammatory in Colorectal Cancer
|
5R01CA073674-14
|
$270,299
|
$270,299
|
KONG, AH-NG
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-08
|
$283,209
|
$283,209
|
JONES, DAVID
|
UNIVERSITY OF UTAH
|
|
Apple peel extract inhibits Cr(VI)-induced lung cancer
|
1R03CA171604-01
|
$74,250
|
$74,250
|
Zhang, Zhuo
|
UNIVERSITY OF KENTUCKY
|
|
Are ACF Surrogate Markers for Chemoprevention?
|
1R01CA159976-01A1
|
$333,362
|
$333,362
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$23,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$44,592
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$1,225,682
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Aspirin/Folate Prevention of Large Bowel Polyps
|
5R01CA059005-17
|
$803,946
|
$803,946
|
Baron, John
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Assessing the role of androgens in breast cancer risk
|
1R01CA166666-01
|
$478,706
|
$478,706
|
Hankinson, Susan
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$235,378
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-26
|
$562,599
|
$45,008
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus
|
5R01CA134571-04
|
$253,607
|
$63,402
|
SOUZA, RHONDA
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$38,893
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$11,200
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$61,747
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer
|
5R01CA129813-05
|
$308,958
|
$308,958
|
BYERS, STEPHEN
|
GEORGETOWN UNIVERSITY
|
|
Bioavailability and activity of dietary naringenin as a chemopreventive agent
|
1R03CA162551-01A1
|
$75,631
|
$75,631
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
Biobehavioral Cancer Prevention and Control Training Program
|
3R25CA092408-12S1
|
$45,391
|
$45,391
|
Patrick, Donald
|
UNIVERSITY OF WASHINGTON
|
|
Biobehavioral Cancer Prevention and Control Training Program
|
5R25CA092408-12
|
$421,086
|
$421,086
|
Patrick, Donald
|
UNIVERSITY OF WASHINGTON
|
|
Biomarkers to Assess Selenium Chemoprevention for NSCLC
|
5R01CA095568-10
|
$587,466
|
$587,466
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Bmi-1 and Skin Cancer Prevention
|
5R01CA131074-05
|
$416,222
|
$416,222
|
ECKERT, RICHARD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
BRCA1 and progesterone receptors in breast cancer
|
4R01CA137102-03
|
$314,392
|
$314,392
|
LEE, EVA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Breast Cancer Prevention by Ayurvedic Medicine Constituents
|
5R01CA142604-03
|
$304,932
|
$304,932
|
Singh, Shivendra
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast Cancer Prevention by Dietary Phytochemicals
|
2R01CA129347-06
|
$279,768
|
$279,768
|
Singh, Shivendra
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$472,022
|
$236,011
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$32,472
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$182,896
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-36S1
|
$76,572
|
$9,954
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-36
|
$7,071,992
|
$919,359
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-37S1
|
$107,460
|
$2,149
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Chemoprevention for this search: $123,477,789
|